Latest news
AI Drug Discovery Has $8.9 Billion in Hype and Zero FDA Approvals: When Does the Bill Come Due? - The Clinical Trial VanguardThe Clinical Trial Vanguard · Sat, 08 Aug 2026 07:29:08 GMTIs GRAIL (GRAL) Fairly Valued Following Galleri Adoption Growth And The FDA Panel Date? - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 05:12:00 GMTRecovery for Replimune: Accelerated Approval for Cancer Drug Twice Spurned by FDA - MedCity NewsMedCity News · Fri, 07 Aug 2026 22:12:34 GMTThis Week at FDA: Inspection reorg, acting CBER chief eyes IND reforms, and more - RAPSRAPS · Fri, 07 Aug 2026 20:43:00 GMTFDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1 - Managed Healthcare ExecutiveManaged Healthcare Executive · Fri, 07 Aug 2026 20:06:51 GMTFDA Approves First mRNA Flu Vaccine - Inside Precision MedicineInside Precision Medicine · Fri, 07 Aug 2026 16:29:40 GMTHeart experts fear Trump’s FDA is ‘ignoring decades of evidence’ as it authorizes new nicotine pouches - Cardiovascular BusinessCardiovascular Business · Fri, 07 Aug 2026 15:47:02 GMTGRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test - PR NewswirePR Newswire · Fri, 07 Aug 2026 15:05:00 GMT